CVE-2023-42435
CVE-2023-42435 is a medium-severity vulnerability in Dexma Dexgate with a CVSS 3.x base score of 5.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-352.
Key facts
- Severity: Medium (CVSS 3.x base score 5.5)
- EPSS exploit prediction: 0% (8th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-352
- Affected product: Dexma Dexgate
- Published:
- Last modified:
Description
The affected product is vulnerable to a cross-site request forgery vulnerability, which may allow an attacker to perform actions with the permissions of a victim user.
Frequently asked questions
- What is CVE-2023-42435?
- The affected product is vulnerable to a cross-site request forgery vulnerability, which may allow an attacker to perform actions with the permissions of a victim user.
- How severe is CVE-2023-42435?
- CVE-2023-42435 has a CVSS 3.x base score of 5.5, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is low, integrity low, and availability low.
- Is CVE-2023-42435 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (8th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2023-42435?
- CVE-2023-42435 affects Dexma Dexgate. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2023-42435?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- When was CVE-2023-42435 published?
- CVE-2023-42435 was published on 2023-10-19 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:dexma:dexgate:20130114:*:*:*:*:*:*:*
More vulnerabilities in Dexma Dexgate
- CVE-2023-41089 — High (CVSS 8.0): The affected product is vulnerable to an improper authentication vulnerability, which may allow an attacker to…
- CVE-2023-41088 — Medium (CVSS 6.3): The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow…
- CVE-2023-40153 — Medium (CVSS 5.4): The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the…
- CVE-2023-42666 — Medium (CVSS 5.3): The affected product is vulnerable to an exposure of sensitive information to an unauthorized actor vulnerability,…
All CVEs affecting Dexma Dexgate →
Other CWE-352 (Cross-Site Request Forgery (CSRF)) vulnerabilities
- CVE-2025-32642 — Critical (CVSS 10.0): Cross-Site Request Forgery (CSRF) vulnerability in appsbd Vite Coupon vite-coupon allows Remote Code Inclusion.This…
- CVE-2025-23922 — Critical (CVSS 10.0): Cross-Site Request Forgery (CSRF) vulnerability in Harsh iSpring Embedder embed-ispring allows Upload a Web Shell to a…
- CVE-2017-5145 — Critical (CVSS 10.0): An issue was discovered in Carlo Gavazzi VMU-C EM prior to firmware Version A11_U05, and VMU-C PV prior to firmware…
- CVE-2019-25729 — Critical (CVSS 9.8): PDF Signer 3.0 contains a server-side template injection vulnerability that allows unauthenticated attackers to execute…
- CVE-2025-48340 — Critical (CVSS 9.8): Cross-Site Request Forgery (CSRF) vulnerability in Danny Vink User Profile Meta Manager user-profile-meta allows…
- CVE-2025-2907 — Critical (CVSS 9.8): The Order Delivery Date WordPress plugin before 12.3.1 does not have authorization and CSRF checks when importing…
Browse all CWE-352 (Cross-Site Request Forgery (CSRF)) vulnerabilities →